Cargando…
Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.
Autores principales: | Harris, A. L., Mitchell, M. D., Smith, I. E., Powles, T. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011503/ https://www.ncbi.nlm.nih.gov/pubmed/6688732 |
Ejemplares similares
-
The effect of sulindac on growth differentiation factor 15 and 13,14-dihydro-15-keto prostaglandin A(2 )in nipple aspirate fluid
por: Thompson, PA, et al.
Publicado: (2009) -
Effect of route of administration of dinoprost tromethamine on plasma profiles of 13,14-dihydro-15-keto-prostaglandin F(2α) and progesterone in lactating Holstein cows
por: Mezera, M.A., et al.
Publicado: (2021) -
Use of urinary 13,14, dihydro-15-keto-prostaglandin F(2α) (PGFM) concentrations to diagnose pregnancy and predict parturition in the giant panda (Ailuropoda melanolecua)
por: Roberts, Beth M., et al.
Publicado: (2018) -
Changes in the C-reactive protein and 13,14-dihydro-15-keto-prostaglandin F(2α) concentrations of uterine lavage samples after the administration of povidone-iodine in cows
por: ANDO, Yuki, et al.
Publicado: (2022) -
Non-Invasive Pregnancy Diagnosis in Big Cats using the PGFM (13,14-dihydro-15-keto-PGF(2α)) Assay
por: Dehnhard, Martin, et al.
Publicado: (2015)